EPM
BSX icon

Equitec Proprietary Markets’s Boston Scientific BSX Stock Holding History

Equitec Proprietary Markets’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$889K Buy
20,824
+9,724
+88% +$528K 0.16% 36
2026
Q1 		$697K Buy
+11,100
New +$888K 0.37% 31
2015
Q1 		– Sell
-11,975
Closed -$159K – 207
2014
Q4 		$159K Buy
+11,975
New +$153K 0.01% 360

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Equitec Proprietary Markets's BSX Position: Q2 2026 in Review

Equitec Proprietary Markets increased its Boston Scientific (BSX) stake by 88% in Q2 2026, buying an estimated $528K and bringing the position to 20,824 shares worth $889K. The position accounts for 0.16% of the portfolio, ranked #36.

Equitec Proprietary Markets first reported a position in BSX in Q4 2014 and has held it in 3 quarters since. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Equitec Proprietary Markets held 20,824 shares of Boston Scientific worth $889K as of Q2 2026.
  • Equitec Proprietary Markets bought 9,724 Boston Scientific shares in Q2 2026, an estimated $528K.
  • Boston Scientific made up 0.16% of Equitec Proprietary Markets's portfolio in Q2 2026, its #36 holding.
  • Equitec Proprietary Markets first reported a position in Boston Scientific in Q4 2014 and has held it in 3 quarters since.
  • 1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Equitec Proprietary Markets's 13F filing for Q2 2026, filed 20 Jul 2026.